|
|
Volumn 298, Issue 2, 2007, Pages 163-164
|
|
Novel therapies target myasthenia gravis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLCHOLINE;
CYCLOPHOSPHAMIDE;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
ANTISENSE OLIGONUCLEOTIDE;
CHOLINESTERASE INHIBITOR;
EN101;
IMMUNOSUPPRESSIVE AGENT;
UNCLASSIFIED DRUG;
CANCER SUSCEPTIBILITY;
DENDRITIC CELL;
HUMAN;
IMMUNE RESPONSE;
INFECTION SENSITIVITY;
MYASTHENIA GRAVIS;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SCIENTIST;
SHORT SURVEY;
TREATMENT RESPONSE;
ANIMAL;
ARTICLE;
ANIMALS;
CHOLINESTERASE INHIBITORS;
CYCLOPHOSPHAMIDE;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MYASTHENIA GRAVIS;
OLIGONUCLEOTIDES, ANTISENSE;
|
|
EID: 34447267514
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.298.2.163 Document Type: Short Survey |
|
Times cited : (4)
|
|
References (0)
|